CXCL14 and fatty liver disease: In patients with advanced hepatic steatosis (score ≥ 3), chemokine (C-X-C motif) ligand 14 (CXCL14), interleukin-1 family member 10 (IL1F10), and interleukin 8 receptor β (IL8RB) had a significant differential expression (P ≤ 0.05) as compared to those with mild steatosis (score ≤ 2) (Table 2).